Semnur Pharmaceuticals, Inc.
Pharmaceutical company · Palo Alto, California, United States · OTC: SMNR
Semnur Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Palo Alto, California, United States. Its earliest recorded incorporation is in 2013. Its shares trade on OTC under the ticker SMNR. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2013.
Semnur Pharmaceuticals at a glance
What does Semnur Pharmaceuticals do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $6 million sold (2013).
Frequently asked questions about Semnur Pharmaceuticals
Where is Semnur Pharmaceuticals headquartered?
Semnur Pharmaceuticals, Inc. is headquartered in Palo Alto, California, United States.
What does Semnur Pharmaceuticals do?
Semnur Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Semnur Pharmaceuticals a public company?
Yes. Semnur Pharmaceuticals, Inc. trades on OTC under the ticker SMNR.
When was Semnur Pharmaceuticals founded?
The earliest incorporation on record for Semnur Pharmaceuticals, Inc. is in 2013, according to public company registers.
Similar companies
- TheRas, Inc.Palo Alto, California, United States
- Evommune, Inc.Palo Alto, California, United States
- Anacor Pharmaceuticals, Inc.Palo Alto, California, United States
- Vincerx Pharma, Inc.Palo Alto, California, United States
- BridgeBio Pharma, Inc.Palo Alto, California, United States
- Capacity Bio, Inc.Palo Alto, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences